4//SEC Filing
Clem Kerry M 4
Accession 0001209191-23-022751
CIK 0001008848other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:40 PM ET
Size
5.6 KB
Accession
0001209191-23-022751
Insider Transaction Report
Form 4
Clem Kerry M
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-31+77,300→ 77,300 totalExercise: $0.59Exp: 2033-03-31→ Common Stock (77,300 underlying)
Footnotes (1)
- [F1]Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to the options vest in equal quarterly installments over two years beginning on January 1, 2023 with the first quarterly installment vesting on April 1, 2023.
Documents
Issuer
Acorda Therapeutics, Inc.
CIK 0001008848
Entity typeother
Related Parties
1- filerCIK 0001883938
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:40 PM ET
- Size
- 5.6 KB